1. Home
  2. List
Reference Patent

Reference - List

  • 29 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / drug therapy)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Human and Animal Cells HuH-7 , Hep G2(RCB1648) Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach.
Human and Animal Cells SSP-25(RCB1293), RBE(RCB1292) Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Human and Animal Cells Hepa 1-6(RCB1638) The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors.
Human and Animal Cells HuH-7 First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Human and Animal Cells HuH-6(RCB1367) A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
Human and Animal Cells Hep G2 (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Human and Animal Cells HuH-7 Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.
Human and Animal Cells Li-7(RCB1941) ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.
Human and Animal Cells HuH-7 TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Human and Animal Cells MKN7(RCB0999) Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU.
Human and Animal Cells HuH-7(RCB1942) Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.
Human and Animal Cells HuH-7 Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Human and Animal Cells HuH-7 Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.
Medaka fli1::GFP (TG1206) , Kyoto-Cab Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
Human and Animal Cells Hep G2(RCB1886) Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Human and Animal Cells HuCCT1(RCB1960) Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma.
Human and Animal Cells HuH-7 Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Human and Animal Cells Hep G2 , HuH-7 Growth inhibition by novel liposomes including trehalose surfactant against hepatocarcinoma cells along with apoptosis.
Human and Animal Cells HuH-7 Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.